Publications by authors named "Benito Casu"

Claim this Profile
S
Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins.
Annamaria Naggi, Cristina Gardini, Giacomo Pedrinola, Lucio Mauri, Elena Urso, Benito Casu

J Pharm Biomed Anal· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-visiting the structure of heparin.
Benito Casu, Annamaria Naggi, Giangiacomo Torri

Carbohydr Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosaminoglycans: anticoagulant and nonanticoagulant actions: a short history of symposia held at villa vigoni.
Job Harenberg, Benito Casu, Roland Krämer, Giangiacomo Torri, Annamaria Naggi

Semin Thromb Hemost· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Anna Alekseeva, Benito Casu, Giuseppe Cassinelli, Marco Guerrini, Giangiacomo Torri

Anal Bioanal Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.
Christian Viskov, Stefano Elli, Elena Urso, Davide Gaudesi, Pierre Mourier, Benito Casu

J Biol Chem· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling structural information from complex mixtures utilizing correlation spectroscopy applied to HSQC spectra.
Timothy R Rudd, Eleonora Macchi, Laura Muzi, Monica Ferro, Davide Gaudesi, Benito Casu

Anal Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.
Anna Alekseeva, Benito Casu, Giangiacomo Torri, Sabrina Pierro, Annamaria Naggi

Anal Biochem· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
Marco Guerrini, Stefano Elli, Pierre Mourier, Timothy R Rudd, Davide Gaudesi, Benito Casu

Biochem J· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives.
Martin Schlesinger, Patrick Schmitz, Reiner Zeisig, Annamaria Naggi, Giangiacomo Torri, Benito Casu

Thromb Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
Joseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, Annamaria Naggi, Giangiacomo Torri, Benito Casu

Clin Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.
Marco Guerrini, Stefano Elli, Davide Gaudesi, Giangiacomo Torri, Benito Casu

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Benito Casu, Annamaria Naggi, Giangiacomo Torri

Matrix Biol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin and its derivatives - present and future.
Job Harenberg, Benito Casu

Thromb Haemost· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tainted heparin story: an update.
Marco Guerrini, Zachary Shriver, Antonella Bisio, Annamaria Naggi, Benito Casu

Thromb Haemost· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthogonal analytical approaches to detect potential contaminants in heparin.
Marco Guerrini, Zhenqing Zhang, Zachary Shriver, Annamaria Naggi, Sayaka Masuko, Benito Casu

Proc Natl Acad Sci U S A· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-anticoagulant heparins and inhibition of cancer.
Benito Casu, Israel Vlodavsky, Ralph D Sanderson

Pathophysiol Haemost Thromb· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
Sara Guglier, Milos Hricovíni, Rahul Raman, Laura Polito, Giangiacomo Torri, Benito Casu

Biochemistry· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue.
Marco Guerrini, Sara Guglieri, Benito Casu, Giangiacomo Torri, Pierre Mourier

J Biol Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.
Marco Guerrini, Daniela Beccati, Zachary Shriver, Annamaria Naggi, Karthik Viswanathan, Benito Casu

Nat Biotechnol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparanase, heparin and the coagulation system in cancer progression.
Israel Vlodavsky, Neta Ilan, Yona Nadir, Benjamin Brenner, Ben-Zion Katz, Benito Casu

Thromb Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Nina Hostettler, Annamaria Naggi, Giangiacomo Torri, Riva Ishai-Michaeli, Benito Casu

FASEB J· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
Yang Yang, Veronica MacLeod, Yuemeng Dai, Yekaterina Khotskaya-Sample, Zachary Shriver, Benito Casu

Blood· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Israel Vlodavsky, Neta Ilan, Annamaria Naggi, Benito Casu

Curr Pharm Des· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Antonella Bisio, Alessandra Mantegazza, Elena Urso, Annamaria Naggi, Giangiacomo Torri, Benito Casu

Semin Thromb Hemost· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis.
Marjut Borgenström, Anni Wärri, Katri Hiilesvuo, Rami Käkönen, Sanna Käkönen, Benito Casu

Semin Thromb Hemost· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis